To better understand the molecular basis of this difference in tumor behavior, we correlated the presence of PET-CT–defined bone lesions in 512 NDMM patients with global gene expression data derived from CD138-selected BM PCs at diagnosis. The gene discussed is SDC1; the disease is neoplasm.